Question 1

Who are the top researchers at Sun Pharma (United States)?

Accepted Answer

Ranked on the quality score, Alan M. Mendelsohn, Abayomi Ogundele and Stephen J. Rozzo lead among researchers whose main affiliation is Sun Pharma (United States).

Question 2

What are the most cited papers from Sun Pharma (United States)?

Accepted Answer

The most cited paper from Sun Pharma (United States) is "Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease" (Abhirup Mandal, Vrinda Gote, Dhananjay Pal et al., 2019), with 157 citations. Next come "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" (110) and "Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)" (101).

Question 3

Which research topics does Sun Pharma (United States) publish most on?

Accepted Answer

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Chronic Myeloid Leukemia Treatments, Dermatology and Skin Diseases and Acne and Rosacea Treatments and Effects.

Question 4

Which keywords describe research at Sun Pharma (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Inflammatory Cytokines, Epidemiology, Immune System, IL-17, TH17 Cells, Quality of Life, Inflammation and Dry Eye Disease.

Question 5

Which fields of science does Sun Pharma (United States) work in?

Accepted Answer

In all years, 62% of research at Sun Pharma (United States) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (62%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (6%). It does 2.2× the world's share of Health Sciences.

Question 6

Is Sun Pharma (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 31% lower than in 2018-2021.